ROS-driven structural and functional fibrinogen modifications are reverted by interleukin-6 inhibition in Giant Cell Arteritis.
暂无分享,去创建一个
N. Taddei | G. Emmi | M. Becatti | D. Prisco | G. Di Scala | A. Bettiol | C. Fiorillo | F. R. Argento | F. Bello | Eleonora Fini